Clinical trial

Exercise Plus Epoetin Alfa in Treating Cancer Patients Who Have Anemia-Related…

NCT00004914 · Northwestern University, Other · Completed

Key facts

NCT number NCT00004914
Title Exercise Plus Epoetin Alfa in Treating Cancer Patients Who Have Anemia-Related Fatigue
Official title A Phase II Trial of Progressive Resistance Training (PRT) Plus Procrit for the Treatment of Anemia-Related Fatigue in Cancer Patients
Lead sponsor Northwestern University, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 2
Study type Interventional
Conditions Anemia, Fatigue, Unspecified Adult Solid Tumor, Protocol Specific
Intervention type Biological, Procedure
Interventions epoetin alfa, physical therapy
Start date Jan 1, 2000
Primary completion Dec 1, 2001
Completion Dec 1, 2001
First posted Mar 4, 2004
Last update posted Jun 6, 2012
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies